Unknown

Dataset Information

Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials.


ABSTRACT:

Objective

The efficacy of cannabidiol (CBD) with and without concomitant clobazam (CLB) was evaluated in stratified analyses of four large randomized controlled trials, two in Lennox-Gastaut syndrome, and two in Dravet syndrome.

Methods

Each trial of CBD (Epidiolex® in the US; Epidyolex® in the EU; 10 and 20 mg/kg/day) was evaluated by CLB use. The treatment ratio was analyzed using negative binomial regression for changes in seizure frequency and logistic regression for the 50% responder rate, where the principle analysis combined both indications and CBD doses in a stratified meta-analysis. Pharmacokinetic data were examined for an exposure/response relationship based on CLB presence/absence. Safety data were analyzed using descriptive statistics.

SUBMITTER: Devinsky O 

PROVIDER: S-EPMC7689899 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature